A Single-arm, Open, Exploratory Clinical Study of Allogeneic CAR-T Cells in the Treatment of Relapsed/Refractory Brain Gliomas With Positive CD70 Expression
Clinical trial NCT06828341 · UNKNOWN
Trial details
- NCT number
- NCT06828341
- Sponsor
- JIANG LONGWEI
- Status
- UNKNOWN
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-13
- Primary completion
- 2024-07-06
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.